|
|
| Balance Sheet |
|
| Zydus Lifesciences Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Pankaj R Patel | | Home : Cadila | Book Value: 145.1076344 | | BSE Code : 532321 | Market Cap: 99425.98 | | NSE Code : ZYDUSLIFE | P / E : 36.99 | |
| |
|
|
|
| (Rs in Cr.) |
 |
 |
| SOURCES OF FUNDS: | | | Share Capital | 101.20 | 102.40 | 102.40 | 102.40 | 102.40 | | Reserves & Surplus | 13538.20 | 13138.10 | 12642.10 | 11157.80 | 8466.80 | | Total Shareholders Funds | 13639.40 | 13240.50 | 12744.50 | 11260.20 | 8569.20 | | Secured Loans | 0.00 | 500.00 | 383.90 | 356.90 | 319.40 | | Unsecured Loans | 4991.50 | 2356.00 | 3715.20 | 3470.50 | 3378.40 | | Total Debt | 4991.50 | 2856.00 | 4099.10 | 3827.40 | 3697.80 | | Total Liabilities | 18630.90 | 16096.50 | 16843.60 | 15087.60 | 12267.00 | | APPLICATION OF FUNDS: | | Gross Block | 7989.60 | 7675.60 | 7009.10 | 6564.20 | 6152.30 | | Less: Accum. Depreciation | 3805.50 | 3339.70 | 2897.10 | 2455.20 | 2219.80 | | Net Block | 4184.10 | 4335.90 | 4112.00 | 4109.00 | 3932.50 | | Capital Work in Progress | 739.30 | 384.00 | 570.50 | 552.60 | 674.90 | | Investments | 4879.30 | 5118.00 | 6470.60 | 6404.10 | 4195.20 | | Inventories | 1782.40 | 1926.30 | 1780.00 | 1394.70 | 1472.50 | | Sundry Debtors | 3505.30 | 2277.70 | 1903.80 | 2456.70 | 2112.10 | | Cash and Bank Balance | 248.10 | 302.60 | 154.00 | 385.30 | 112.10 | | Loans and Advances | 5337.10 | 3532.10 | 3602.40 | 1341.30 | 1295.70 | | Current Liabilities | 1845.60 | 1674.20 | 1638.70 | 1485.60 | 1438.40 | | Provisions | 199.10 | 105.90 | 111.00 | 70.50 | 89.60 | | Net Current Assets | 8828.20 | 6258.60 | 5690.50 | 4021.90 | 3464.40 | | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Assets | 18630.90 | 16096.50 | 16843.60 | 15087.60 | 12267.00 | | Contingent Liabilities | 319.90 | 1797.10 | 1503.90 | 3690.30 | 3100.30 |
|
|
|
|
|